HBM Healthcare Investments - Looking ahead to renewed opportunities
HBM Healthcare Investments (HBMN) posted its first NAV loss in a decade for FY22 (ended 31 March), but, as shown in the chart below, its long-term...
HBM Healthcare Investments - A stellar year to mark 20th anniversary
HBM Healthcare Investments (HBMN) has posted record returns in its 20th anniversary year, with NAV and share price total returns of 52% and 79%...
Video: 2021 life sciences investment opportunities - discussion at Edison Open House Global Healthcare 2021
Edison talks to leading buy-side experts in the United States and Europe, offering their perspective on the major markets – and what global...
HBM Healthcare Investments - Keeping calm amid the market turmoil
HBM Healthcare Investments’ (HBMN’s) portfolio is still in line for a positive FY20 (NAV TR +13.2% at 24 March 2020 compared with the 31 March FY19...
HBM Healthcare Investments - Positive developments for private/public fund
HBM Healthcare Investments (HBMN) reported profits of CHF72m for the third quarter of its financial year, buoyed by the takeover of long-term...
No more insights